Mounjaro®
Starting from £179.99/mo
Start journey Learn moreGetting Wegovy in the UK starts with a single step: a clinical assessment by a registered prescriber who decides whether it is suitable for you. There is no shortcut around that. What can be made easy is everything else — finding a regulated pharmacy, having your consultation reviewed the same day, and receiving the medicine at your door the next working day. Here is what the process actually looks like, and what to watch out for along the way. These are prescription-only medicines, so a prescriber's decision sits at the centre of the whole thing.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Most people searching for an easy way to get Wegovy have already done the reading. They know roughly what semaglutide does, they have seen the trial figures, and they are not looking for a lecture. What they want is a clear path.
The honest answer is that the path has one non-negotiable stage and then a lot of variation in how smooth the rest of it is. The non-negotiable part is clinical assessment. Wegovy is a Prescription-Only Medicine; a prescriber must review your health before any supply can legally happen. That is not bureaucracy for its own sake, it exists because GLP-1 medicines are not right for everyone, and certain conditions, medicines and circumstances require careful thought before starting.
Once you understand that the clinical step is the point rather than the obstacle, the question shifts: which route through that step is least complicated? NHS access to Wegovy exists but sits behind specialist weight management services and, for many people, a significant wait. For a detailed look at how to get Wegovy in the UK across both NHS and private routes, that page covers the full picture. For most people reading this, the fastest legitimate route is a regulated private online pharmacy where the clinical assessment happens the same day.
The NHS guidance on weight management injections is worth a read if you want to understand what the NHS pathway looks like and whether you might qualify.
A good online pharmacy does not just fire a form at you and wave you through. What should happen (and what any pharmacy you choose ought to be doing) is this: a structured health questionnaire, identity verification to confirm you are who you say you are, live weight verification rather than a self-reported number, and then a real clinician reading your answers and making a clinical decision. Not software. A person with prescribing qualifications and GPhC registration who looks at your case specifically.
At nume, that review happens the same day. If you place your order before midday on a working day and our prescriber determines Wegovy is clinically appropriate for you, it is dispatched the same afternoon. A DPD tracking notification arrives on your phone, and the next working day a plain, unbranded box lands at your door, inside it, your pen and everything you need to start. No guesswork, no waiting in a queue for a call back.
If you are curious about how to start Wegovy correctly, that page walks through what the first weeks look like from a clinical standpoint.
The thing our prescribers hear often from new patients: they assumed it would be more complicated. Sometimes the simple version really is the right one, as long as every safety check is in it.
Wegovy's UK licence covers adults with a BMI of 30 or above, or a BMI of 27 to 29.9 alongside at least one weight-related condition such as high blood pressure, high cholesterol, obstructive sleep apnoea or type 2 diabetes. Lower BMI thresholds may apply for some ethnic backgrounds under UK clinical guidance. You can find the specifics on the Wegovy treatment page.
BMI alone does not guarantee that a prescriber will approve treatment, because the assessment covers more ground than a single number. Certain conditions, some medications and a small number of situations mean Wegovy is not the right choice. That is why the clinical review exists. The prescriber is not a barrier; they are the reason a prescription actually means something.
NICE's appraisal of semaglutide for weight management, TA875, sets out the formal criteria and context for NHS use; the private eligibility criteria follow the licensed indications rather than the NHS thresholds, so they can differ.
Cost is something most people factor in early. There is a useful breakdown on the Wegovy pricing page, including what a transparent private price typically covers and what some quoted prices quietly leave out.
Searching for the easiest way to get Wegovy will surface sellers who offer it without any clinical review at all. Some operate on social media. Some list prices well below anything a licensed UK supply chain could support. A few have offered discount codes or time-limited deals on prescription medicines, which is both a regulatory red flag and, in the case of semaglutide specifically, a safety one.
The MHRA has conducted large seizures of counterfeit weight-loss pens in the UK. Some fakes have contained insulin rather than semaglutide, with predictably dangerous results. You can verify any online pharmacy against the GPhC register at pharmacyregulation.org in about thirty seconds; any pharmacy unwilling to give you its registration number is telling you something. It is also worth knowing that some people experience strong emotional reactions while using Wegovy, something a good prescriber will flag and monitor from the outset.
Suspect sellers offering prescription medicines without a clinical assessment can also be reported directly to the MHRA at the Yellow Card scheme.
The easiest route is the one that keeps you safe throughout. If you want to understand what you are actually comparing when you look at different providers, how easy Wegovy really is to access covers the practical realities side by side.
When you are ready, speak to our prescribers through a free consultation, same-day clinical review, no hidden fees, and the whole process handled by a GPhC-registered pharmacy you can verify instantly.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.